All Pharma News
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results

Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
11 Mar 2024
Share Share
Anaptys to Present at TD Cowen™s 44th Annual Health Care Conference

Anaptys to Present at TD Cowen™s 44th Annual Health Care Conference
GLOBENEWSWIRE
29 Feb 2024
Share Share
Anaptys to Present at Guggenheim™s 6th Annual Biotechnology Conference

Anaptys to Present at Guggenheim™s 6th Annual Biotechnology Conference
GLOBENEWSWIRE
31 Jan 2024
Share Share
Anaptys picks up rival to Biogen autoimmune asset from Centessa

Anaptys picks up rival to Biogen autoimmune asset from Centessa
Nick Paul Taylor FIERCE BIOTECH
28 Nov 2023
Share Share
Anaptys Expands Immune Cell Modulator Pipeline

Anaptys Expands Immune Cell Modulator Pipeline
GLOBENEWSWIRE
27 Nov 2023
Share Share
Anaptys Named a BioSpace 2024 Best Places to Work Winner

Anaptys Named a BioSpace 2024 Best Places to Work Winner
GLOBENEWSWIRE
07 Nov 2023
Share Share
Anaptys Announces Third Quarter 2023 Financial Results

Anaptys Announces Third Quarter 2023 Financial Results
GLOBENEWSWIRE
02 Nov 2023
Share Share
Anaptys Announces Participation in November Investor Conferences

Anaptys Announces Participation in November Investor Conferences
GLOBENEWSWIRE
01 Nov 2023
Share Share
Anaptys to Present Phase 1 Data on ANB032

Anaptys to Present Phase 1 Data on ANB032
GLOBENEWSWIRE
11 Oct 2023
Share Share
Chasing Boehringer, Anaptys hits goal in skin disease phase 3

Chasing Boehringer, Anaptys hits goal in skin disease phase 3
Nick Paul Taylor FIERCE BIOTECH
10 Oct 2023
Share Share